Adamas Finance Asia Limited UPDATE: REDEMPTION OF GLOBAL PHARM CONVERTIBLE (8320U)
January 23 2017 - 4:15AM
UK Regulatory
TIDMADAM
RNS Number : 8320U
Adamas Finance Asia Limited
23 January 2017
Adamas Finance Asia Limited
("ADAM" or the "Company")
UPDATE ON REDEMPTION OF GLOBAL PHARM CONVERTIBLE BOND
Further to the announcement on 7 October 2016, the Company
announces that Global Pharm Holdings Group Inc. has yet to drawdown
the new bank loan which triggers the repayment of US$2.7 million to
ADAM. In addition, the target amounts agreed under the Revised
Agreement for October to December 2016 have yet to be paid.
Payments under the Revised Agreement are targets and stated to be
subject to Global Pharm's working capital requirements. The
Directors expect that they will be paid in due course.
Global Pharm has, to date, made payments of approximately
US$6.01 million (net to ADAM) to offset against the original
redemption amount of the Convertible Bond of approximately US$25.05
million (net to ADAM). The outstanding amount of the Convertible
Bond continues to be subject to interest of 26% per annum,
compounded on a daily basis.
The Company's investment manager is in discussions with Global
Pharm and a further announcement will be made in due course.
Terms defined in the announcement of 7 October 2016 have the
same meaning in this announcement.
Enquiries:
Adamas Finance Asia Limited
John Croft +44 (0) 1825 830587
WH Ireland Limited
+44 (0) 113 394
6600
Tim Feather +44 (0) 117 945
Ed Allsopp 3444
First City Public Relations
(Hong Kong) +852 2854 2666
Allan Piper
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCKXLBLDFFBBBL
(END) Dow Jones Newswires
January 23, 2017 04:15 ET (09:15 GMT)
Jade Road Investments (LSE:JADE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Jade Road Investments (LSE:JADE)
Historical Stock Chart
From Jul 2023 to Jul 2024